Biotricity (NASDAQ:BTCY) Stock Price Down 2.5%

Biotricity, Inc. (NASDAQ:BTCY)’s share price fell 2.5% during mid-day trading on Friday . The company traded as low as $0.75 and last traded at $0.75. 23,084 shares were traded during mid-day trading, a decline of 70% from the average session volume of 76,471 shares. The stock had previously closed at $0.77.

Biotricity Stock Down 2.5 %

The stock’s fifty day simple moving average is $0.94 and its 200-day simple moving average is $1.07.

Biotricity (NASDAQ:BTCY) last issued its quarterly earnings results on Thursday, June 27th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by ($0.11). The firm had revenue of $3.18 million during the quarter, compared to the consensus estimate of $3.20 million. On average, equities research analysts expect that Biotricity, Inc. will post -0.43 earnings per share for the current fiscal year.

Institutional Trading of Biotricity

A hedge fund recently bought a new stake in Biotricity stock. Advisor Resource Council purchased a new stake in shares of Biotricity, Inc. (NASDAQ:BTCY) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 79,070 shares of the company’s stock, valued at approximately $117,000. Advisor Resource Council owned about 0.84% of Biotricity as of its most recent filing with the Securities & Exchange Commission. 3.89% of the stock is currently owned by institutional investors.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.